Prologue Research
Joanne DiRinaldo,
Senior VP, Business Development
580 North Fourth Street, Suite 270
Columbus, OH 43215 USA
Phone: 800-906-6565
Fax: 800-790-9953
E-mail:
Web: http://www.procro.com


Provided by MapQuest

 

Company Overview

    Prologue Research, Inc., is a leading global oncology contract research organization (CRO) founded in 1998, offering a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology. Prologue provides its clients with world-class experience in running oncology trials, a deeply-qualified staff, access to an extensive investigator database, and state-of-the-art computerized systems uniquely designed for complicated oncology trials. We offer experience and talent that enable more efficient product development while maintaining unparalleled quality.

    To date, Prologue has provided support to nearly 100 trials treating over 18,500 patients at more than 650 sites from a database of over 12,000 investigators.

 

International Oncology Expertise

    Prologue -- The Oncology CRO. Our name says it all.

    It is our dedication to detail and expertise in the oncology field that set us apart from other CROs. We take great pride in being a niche CRO dedicated to one therapeutic field: oncology. This streamlined focus allows us to provide a level of attention to detail that others can only promise.

    Prologue has the oncology expertise to design and manage all phases of your clinical trial. We also have working relationships with global experts in clinical trial management, enabling the successful, seamless completion of large international oncology studies.

 

Oncology Clinical Trial Services

    Program Planning / Study Design

    • protocol design and therapeutic consultation
    Site Feasibility and Initiation
    • strong relationship with oncology-focused sites
    • faster time to open
    Project Management
    • extensive clinical experience
    • unique PM model; heavy focus on client service
    Monitoring
    • regional, local-language oncology CRAs
    Pharmacovigilance
    • industry standard safety systems
    Medical Monitoring
    • in-house oncologist support
    Data Monitoring Committee (DMC)
    • relationship with key oncology opinion leaders
    Data Management
    • paper-based or EDC options
    Biostatistics
    • experts in Adaptive Trial Design
    • oncology-experienced programmers
    Medical Writing
    • IND development through NDA submission
    Rescue Work

 

For More Information

    For further information about Prologue or a proposal on your next oncology project, please contact Joanne DiRinaldo at 800-906-6565 or by email (jdirinaldo@procro.com).

    For details about our global oncology clinical trial experience, please visit our website at www.procro.com to request a flyer.

 

Contact Information

    Prologue Research
    Joanne DiRinaldo,
    Senior VP, Business Development
    580 North Fourth Street, Suite 270
    Columbus, OH 43215 USA
    Phone: 800-906-6565
    Fax: 800-790-9953
    E-mail:

    If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:

Address:

City:

State:

Zip:

Phone:

Email address:

Message:

 

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.


Back to Profiles of Industry Providers


Click here to access this Center's WWW home page.

Last updated on August 21, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA